Tuesday - September 30, 2025

Category Archives: Europe

Global Semiconductor Precision Parts Market to Reach USD 33.09 Billion by 2030, Expansion Creates Strategic Opportunities | Arizton

Semiconductor Precision Parts Market Research Report by Arizton Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030. According to Arizton research, the global semiconductor precision parts market size was valued at USD 20.25 billion … Continue reading →

Protein4Life.ro Blog Becomes Romania’s Leading Source for Nutritional Education

Protein4Life.ro publishes comprehensive guide on blog, providing Romanian consumers with evidence-based information on health optimization backed by 18 years of expertise. Protein4Life.ro Romania’s most trusted supplements platform introduces science-based educational guide on blog, addressing growing demand for evidence-based health information … Continue reading →

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Innovations by 180+ Global Leaders – DelveInsight | Featuring GenSight Biologics, Ultragenyx Pharmaceutical, MeiraGTx

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025 Adeno-Associated Virus (AAV) Vectors in Gene Therapy companies are Nanoscope Therapeutics, REGENXBIO, Astellas Gene Therapy, GeneCradle Therapeutics, Asklepios BioPharmaceutical, 4D Molecular Therapeutics, Adverum Biotechnologies, Rocket Pharmaceuticals, Innostellar Biotherapeutics, Passage Bio, Aspa … Continue reading →

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: Epidemiology, Therapies, Companies, DelveInsight | Key players include AstraZeneca, Boehringer Ingelheim, Genentech/Roc

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market The total market size of EGFR mNSCLC in the 7MM was ~USD 4,000 million in 2023.   Emerging EGFR-NSCLC therapies—such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, … Continue reading →

C-MET Metastatic NSCLC Market: Epidemiology, Therapies, Companies, DelveInsight | Novartis, Merck, EMD Serono, AbbVie, Regeneron Pharmaceuticals, Mythic Therapeutics, Apollomics, Johnson & Johnson Inn

C-MET Metastatic NSCLC Market In 2023, the US accounted for the maximum share of the total C-MET Metastatic NSCLC Market in the 7MM, i.e., approximately 75%. Emerging C-MET Metastatic NSCLC therapies—such as TABRECTA, TEPMETKO, Telisotuzumab Vedotin, REGN5093, REGN5093-M114, APL-101, MYTX-011, … Continue reading →

Relapsed/refractory acute myeloid leukemia (AML) Pipeline 2025: Pioneering Clinical Developments by 50+ Global Leaders – DelveInsight | Featuring Ascentage Pharma, Cullinan Oncology, Kronos Bio, Maxin

Relapsed/refractory acute myeloid leukemia Pipeline 2025 DelveInsight’s, “Relapsed/refractory acute myeloid leukemia (AML)- Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the pipeline drug profiles, … Continue reading →

Pancreatic Ductal Adenocarcinoma Pipeline 2025: Pioneering Clinical Developments by 80+ Global Leaders – DelveInsight, SignalChem Lifesciences, Bristol-Myers Squibb, AstraZeneca, REVOLUTION Medicines

Pancreatic Ductal Adenocarcinoma Market Key companies in pancreatic ductal adenocarcinoma market include Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, Incyte Corporation, I-Mab Biopharma, Medicenna Therapeutics, and Tarveda Therapeutics. With … Continue reading →

Metastatic Renal Cell Carcinoma Pipeline 2025: Pioneering Clinical Developments by 40+ Global Leaders – DelveInsight | Novartis Pharmaceuticals, Vaccibody, SillaJen, Chongqing Precision Biotech

Metastatic Renal Cell Carcinoma Pipeline 2025 Key companies in the metastatic renal cell carcinoma pipeline include AstraZeneca, Genentech, Sumitomo Dainippon Pharma, Allogene Therapeutics, Nektar Therapeutics, Eli Lilly and Company, Xynomic Pharmaceuticals, AnewPharma, HUTCHMED, MedImmune, Incyte Corporation, NiKang Therapeutics, OncoC4, Nanobiotix, … Continue reading →

Oligometastatic Disease Market: Epidemiology, Therapies, Companies | DelveInsight | Key companies in this space include ImmuneSensor Therapeutics, POINT Biopharma, Novartis Pharmaceuticals, AstraZenec

Oligometastatic Disease Market According to DelveInsight’s patient-based forecasting model, the oligometastatic disease market size in the 7MM was around USD 1,900 million in 2023, which is expected to significantly increase over the forecast period (2024-2034), owing to an increase in … Continue reading →